United States: A High Bar For Antibody Genus Claims To Meet The Enablement Requirement - Baker Botts

The United States Court of Appeals for the Federal Circuit recently issued its opinion in Amgen v. Sanofi, finding Amgen's antibody claims invalid for lack of enablement.